In addition, we demonstrated the effectiveness of combined FAK/SRC and MEK inhibition in enhancing the response of both resistant and sensitive MPNST cells to MEKis (Figure 7). The gene discussed is PTK2; the disease is malignant peripheral nerve sheath tumor.